Multimethod Approach to Understanding the Different Affinity for the 5-HT<sub>1A</sub> Receptor of Three Regioisomers of Novel Arylpiperazine Salicylamide Ligand-Reference-Cited by-同舟云学术

Multimethod Approach to Understanding the Different Affinity for the 5-HT_1A Receptor of Three Regioisomers of Novel Arylpiperazine Salicylamide Ligand

Published:2023-07-15 Issue:8 Volume:23 Page:5827-5838
ISSN:1528-7483
Container-title:Crystal Growth & Design
language:en
Short-container-title:Crystal Growth & Design

Author:

Pindelska Edyta¹^ORCID,Mogilnicki Mateusz A.²,Jaśkowska Jolanta³,Madura Izabela D.⁴^ORCID

Affiliation:

1. Department of Analytical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-093 Warsaw, Poland

2. Scientific Circle “Spektrum” at Department of Analytical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-093 Warsaw, Poland

3. Department of Organic Chemistry and Technology, Faculty of Chemical and Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland

4. Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland

Funder

Warszawski Uniwersytet Medyczny

Publisher

American Chemical Society (ACS)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.cgd.3c00438

Reference53 articles.

1. Guidelines for the successful generation of protein–ligand complex crystals

2. Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects

3. The use of small-molecule structures to complement protein–ligand crystal structures in drug discovery

4. Force Field Optimization Guided by Small Molecule Crystal Lattice Data Enables Consistent Sub-Angstrom Protein–Ligand Docking

5. Application of Fragment-Based Drug Discovery to Versatile Targets

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, computational and pharmacological evaluation of novel N-{4-[2-(4-aryl-piperazin-1-yl)ethyl]phenyl}-arylamides;Journal of the Serbian Chemical Society;2023